Back to Journals » OncoTargets and Therapy » Volume 11

Review

The return of gemtuzumab ozogamicin: a humanized anti-CD33 monoclonal antibody–drug conjugate for the treatment of newly diagnosed acute myeloid leukemia

       
Total article views   HTML views PDF downloads Totals
14,269 Dovepress* 11,234+ 1,350 12,584
PubMed Central* 3,035 894 3,929
Totals 14,269 2,244 16,513
*Since 22 November 2018

View citations on PubMed Central and Google Scholar